Delivery Order SPE2DB20D3103-SPE2DB23FN2M4

Award Date 5/1/23
Potential Completion Date 5/2/23
Potential Value $5.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $3,532.65, is for the delivery of ANUCORT-HC 25 MG SUPPOSITORY 12S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of May 11, 2023. The contract was awarded on May 10, 2023, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of ANUCORT-HC 25 MG SUPPOSITORY 12S, a pharmaceutical product. The $2,764.40 fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,028.09 firm-fixed-price delivery order is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 24S, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This federal contract award, valued at $1,165.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is a delivery order for the supply of ANUCORT-HC 25 MG SUPPOSITORY 12S, a pharmaceutical product. The award has an ultimate completion date of October 9, 2024 and is a firm fixed price contract. The contract is not a set-aside. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts...
This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $2,100.75, to provide ANUCORT-HC 25 MG SUPPOSITORY 24S to the Defense Logistics Agency (DLA). The order is placed under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,790.72, is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 24S medical products. The contract has an ultimate completion date of March 7, 2025 and is not designated as a set-aside award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,000.52, is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 24S, a medical product. The contract is a firm fixed-price delivery order with a period of performance through May 14, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
This federal contract award, valued at $27,314.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ANUCORT-HC 25 MG SUPPOSITORY 24S, a medical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ANUCORT-HC 25 MG SUPPOSITORY 24S. The contract is a Delivery Order with a Firm Fixed Price, valued at $6,413.64, and has an ultimate completion date of August 29, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, through its Corporate Office Division, will be responsible for providing these...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF6PF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,460.01 firm-fixed-price delivery order contract is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 12S, a pharmaceutical product. The contract has a completion date of February 28, 2025 and was awarded on February 27, 2025. This award is associated with a larger Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FN2M4
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of ANUCORT-HC 25 MG SUPPOSITORY 24S medical supplies. The contract, valued at $5,662.87, was awarded by the Defense Logistics Agency (DLA) on May 1, 2023, with a completion date of May 2, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:09 AM